Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:ADMP
FechaHoraFuenteTítuloSímboloCompañía
24/07/202315:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/07/202315:37Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/06/202306:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces NIH Grant Funding for the Treatment of Alcohol Use DisorderNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/06/202306:30GlobeNewswire Inc.Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose PreventionNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/06/202305:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/06/202314:22Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
30/05/202317:14Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
26/05/202315:29Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
25/05/202315:26GlobeNewswire Inc.Adamis Pharmaceuticals Announces Closing of the Merger with DMK PharmaceuticalsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
19/05/202311:00GlobeNewswire Inc.Adamis Pharmaceuticals Announces Reverse Stock SplitNASDAQ:ADMPAdamis Pharmaceuticals Corporation
15/05/202315:47GlobeNewswire Inc.Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
08/05/202315:05GlobeNewswire Inc.Adamis Pharmaceuticals Schedules First Quarter 2023 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/05/202316:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
01/05/202315:32Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
13/04/202315:53Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202315:24GlobeNewswire Inc.Adamis Pharmaceuticals Reports Full Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
16/03/202314:59Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202315:01GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Fourth Quarter and Full Year 2022 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/03/202307:30GlobeNewswire Inc.Adamis Pharmaceuticals Announces $3.0 Million Registered Direct OfferingNASDAQ:ADMPAdamis Pharmaceuticals Corporation
27/02/202315:05GlobeNewswire Inc.Adamis Pharmaceuticals and DMK Pharmaceuticals Announce Agreement and Plan of MergerNASDAQ:ADMPAdamis Pharmaceuticals Corporation
22/02/202315:01GlobeNewswire Inc.Nasdaq Grants Adamis Pharmaceuticals’ Request for Extension to Comply with Continued Listing RequirementsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/11/202215:59Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
14/11/202215:10GlobeNewswire Inc.Adamis Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/11/202215:05GlobeNewswire Inc.Adamis Pharmaceuticals Schedules Third Quarter 2022 Financial Results Conference Call and Corporate UpdateNASDAQ:ADMPAdamis Pharmaceuticals Corporation
03/10/202215:30GlobeNewswire Inc.Adamis Announces Review of Strategic AlternativesNASDAQ:ADMPAdamis Pharmaceuticals Corporation
23/09/202216:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
21/09/202206:30GlobeNewswire Inc.Adamis Provides Update on the Phase 2/3 Trial of Tempol in COVID-19 Positive High-Risk SubjectsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
20/09/202205:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
12/09/202215:05GlobeNewswire Inc.Adamis Provides an Enrollment Update on the Phase 2/3 Study of Tempol in COVID-19 Positive High-Risk SubjectsNASDAQ:ADMPAdamis Pharmaceuticals Corporation
09/09/202216:13Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP

Su Consulta Reciente